BREAKOUTS..RUNNERS AND HOT PENNIES
Last Post: 11/20/2024 6:01:48 AM
Board Marks: 234
Posts Today: 1
Board Views Today: 1021
Post
Subject
Author
Posted On
Recent Articles
- NIP Group's Upcoming Financial Report and Company Overview
- Recursion and Exscientia Unite for Groundbreaking Drug Discovery
- Solaris Resources Restructures for Future Growth and Success
- Septerna's Growth Acceleration in GPCR Therapy Development
- PyroGenesis Outlines Growth Opportunities Amid Political Changes
- Global-e's Strong Q3 2024 Results Show Remarkable Growth
- LuxUrban Hotels' Q3 2024 Performance Sets Foundation for Growth
- BioStem Technologies Reinforces Commitment to Wound Care Market
- VitalHub's Innovative SHREWD System Enhances Patient Care
- C4 Therapeutics Enhances Board with Steve Hoerter's Expertise
- Minera Alamos Secures C$8.5 Million in Private Placement Funding
- Willis Sustainable Fuels Partners with McDermott for SAF Project
- Pasithea Therapeutics Progresses with PAS-004 in Cancer Trials
- CompScience Welcomes Jeremy Silver as New SVP for AI Growth
- Scatec Advances Renewable Energy Projects Through Strategic Sale
- Renalytix plc Provides Q1 Financial Highlights and Future Growth
- Alliance Witan PLC Updates Net Asset Value Metrics
- McDermott Partners with Willis for Green Aviation Fuel Projects
- Kaspi.kz Announces Key Decisions from Extraordinary Meeting
- TTEC Digital Earns Major Contender Spot in 2024 PEAK Matrix
- Innovative Approaches to RET-Positive Lung Cancer Research
- Home Services Industry Shows Promising Growth for 2025
- ZIM's Remarkable Q3 2024 Results and Future Outlook
- BAE Systems Partners with JetZero for Sustainable Aviation
- Spire Inc. Announces Strong Fiscal 2024 Earnings Performance
- Eupraxia's DiffuSphere™ Technology Achieves Lasting Therapeutic Relief
- Innovative New Approach to Treat RET-Positive Cancers
- UCB Receives FDA Approval for BIMZELX in Hidradenitis Suppurativa
- Pathios Therapeutics Launches First Patient Dosing of PTT-4256
- Exploring REM-422's Promising Role Against AML
- Acurx Pharmaceuticals Embraces Bitcoin as Reserve Asset
- Acurx Pharmaceuticals Opts for Bitcoin in Treasury Strategy
- Del-Air Expands Services with Acquisition of Colman Heating
- Harfang Exploration Expands Gold Discovery with Positive Results
- Global Motorcycle Filter Market Anticipates Strong Growth to $6.36B
- Algorhythm Holdings' Transformative Third Quarter Results 2024
- Connexa Secures Nasdaq Approval for Yuanyu Acquisition Deal
- RYVYL Adjusts Investor Agreement for Enhanced Financial Strategy
- Automotive Finance Market Projected to Exceed $544 Billion
- Future Growth of Autonomous Networks Market to $30.26 Billion
- Mirasol's Exploration Phase Initiates at Sobek Copper-Gold Project
- Elevate Your Privacy: MillionaireMatch Unveils Confidentiality Guard™
- Shanghai Electric's Commitment to Africa's Power Evolution
- Designer Brands Inc. Schedules Earnings Call for Q3 2024
- Timken Company Sets to Engage Investors at Key Conferences
- Exploring Cultural Bridges: The 6th China-France Forum
- Seismic Protection Devices Market Insight: Growth and Innovation
- Exploring the Future Growth of the SDx Market by 2034
- Growth Projections for Idiopathic Pulmonary Fibrosis Treatments
- Exploring the Future of the In Vitro Diagnostics Market